Literature DB >> 34723953

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria.

Dionysios C Watson1, Sadie Johnson2, Akeem Santos3, Mei Yin4, Defne Bayik2, Justin D Lathia5, Mohammed Dwidar6.   

Abstract

Diverse bacterial species secrete ~20-300 nm extracellular vesicles (EVs), comprised of lipids, proteins, nucleic acids, glycans, and other molecules derived from the parental cells. EVs function as intra- and inter-species communication vectors while also contributing to the interaction between bacteria and host organisms in the context of infection and colonization. Given the multitude of functions attributed to EVs in health and disease, there is a growing interest in isolating EVs for in vitro and in vivo studies. It was hypothesized that the separation of EVs based on physical properties, namely size, would facilitate the isolation of vesicles from diverse bacterial cultures. The isolation workflow consists of centrifugation, filtration, ultrafiltration, and size-exclusion chromatography (SEC) for the isolation of EVs from bacterial cultures. A pump-driven tangential flow filtration (TFF) step was incorporated to enhance scalability, enabling the isolation of material from liters of starting cell culture. Escherichia coli was used as a model system expressing EV-associated nanoluciferase and non-EV-associated mCherry as reporter proteins. The nanoluciferase was targeted to the EVs by fusing its N-terminus with cytolysin A. Early chromatography fractions containing 20-100 nm EVs with associated cytolysin A - nanoLuc were distinct from the later fractions containing the free proteins. The presence of EV-associated nanoluciferase was confirmed by immunogold labeling and transmission electron microscopy. This EV isolation workflow is applicable to other human gut-associated gram-negative and gram-positive bacterial species. In conclusion, combining centrifugation, filtration, ultrafiltration/TFF, and SEC enables scalable isolation of EVs from diverse bacterial species. Employing a standardized isolation workflow will facilitate comparative studies of microbial EVs across species.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34723953      PMCID: PMC8729794          DOI: 10.3791/63155

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

Review 1.  Structures of gram-negative cell walls and their derived membrane vesicles.

Authors:  T J Beveridge
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

2.  Engineered bacterial outer membrane vesicles with enhanced functionality.

Authors:  Jae-Young Kim; Anne M Doody; David J Chen; Gina H Cremona; Michael L Shuler; David Putnam; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2008-04-09       Impact factor: 5.469

3.  Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.

Authors:  Helen Petousis-Harris; Janine Paynter; Jane Morgan; Peter Saxton; Barbara McArdle; Felicity Goodyear-Smith; Steven Black
Journal:  Lancet       Date:  2017-07-10       Impact factor: 79.321

4.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

5.  Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae.

Authors:  S N Chatterjee; J Das
Journal:  J Gen Microbiol       Date:  1967-10

6.  Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin.

Authors:  Satsuki Kato; Yusuke Kowashi; Donald R Demuth
Journal:  Microb Pathog       Date:  2002-01       Impact factor: 3.738

7.  Membrane vesicles traffic signals and facilitate group activities in a prokaryote.

Authors:  Lauren M Mashburn; Marvin Whiteley
Journal:  Nature       Date:  2005-09-15       Impact factor: 49.962

8.  Efficient production and enhanced tumor delivery of engineered extracellular vesicles.

Authors:  Dionysios C Watson; Defne Bayik; Avinash Srivatsan; Cristina Bergamaschi; Antonio Valentin; Gang Niu; Jenifer Bear; Mitchell Monninger; Mei Sun; Aizea Morales-Kastresana; Jennifer C Jones; Barbara K Felber; Xiaoyuan Chen; Ihsan Gursel; George N Pavlakis
Journal:  Biomaterials       Date:  2016-07-06       Impact factor: 12.479

9.  Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes.

Authors:  Dionysios C Watson; Bryant C Yung; Cristina Bergamaschi; Bhabadeb Chowdhury; Jenifer Bear; Dimitris Stellas; Aizea Morales-Kastresana; Jennifer C Jones; Barbara K Felber; Xiaoyuan Chen; George N Pavlakis
Journal:  J Extracell Vesicles       Date:  2018-02-28

10.  Outer membrane vesicles of Helicobacter pylori TK1402 are involved in biofilm formation.

Authors:  Hideo Yonezawa; Takako Osaki; Satoshi Kurata; Minoru Fukuda; Hayato Kawakami; Kuniyasu Ochiai; Tomoko Hanawa; Shigeru Kamiya
Journal:  BMC Microbiol       Date:  2009-09-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.